Adhd - Articles - Page 3 | CARLAT PUBLISHING

Note From the Editor-in-Chief

Note from the Editor In Chief, CCPR, April/May/June 2025

April 1, 2025

Joshua D. Feder, MD

Dr. Feder has no financial relationships with companies related to this material.

Welcome back to CCPR! We interview Dr. Kristin Cadenhead on psychotic-like experiences, Dr. David Beckman on substance-related psychosis, and Julie Dopheide, PharmD, on metabolic-sparing antipsychotics. We also cover selective mutism, cardiovascular effects of ADHD medications, and a caution from Danielle Reynolds, MS IV, on Delta-8 – warn your patients!

Expert Q&A

ADHD, Stimulants, and Substance Use

April 1, 2025

Sara Polley, MD

Sara Polley, MD, Chief Medical Officer, Ellie Mental Health.

Dr. Polley has no financial relationships with companies related to this material.

Dr. Polley clarifies when to use stimulants in patients with ADHD and substance use disorders and how to address the underlying addiction.

Audio Course - Adult ADHD: Comprehensive Diagnosis and Treatment

Commuter Audio Course

March 22, 2025

Greg Malzberg, MD

Gregory Malzberg, MD. Attending Psychiatrist & Assistant Clinical Professor, Mount Sinai West, New York, NY. Creator, PsychoFarm.

Lawrence H. Diller, MD Private Practice, Behavioral Pediatrics, Walnut Creek, California Clinical Faculty, UCSF School of Medicine Author, The Last Normal Child, Running on Ritalin and Should I Medicate My Child?

Doctors Malzberg and Diller have disclosed that they have no significant relationships with or financial interests in any commercial companies pertaining to this educational activity.

Welcome to our course on treating ADHD in adults. Throughout these modules, we will dive into the latest approaches to understanding, diagnosing, and managing ADHD in adult patients. Whether you're refining your skills or building a foundation, this course is designed to provide practical, evidence-based strategies that you can apply in your practice.

Audio Issue

Audio Issue, Early Childhood Psychiatry, Oct/Nov/Dec 2024

March 20, 2025

Joshua Feder, MD

Clinical Update

How to Select a Stimulant for Adult ADHD

March 1, 2025

Greg Malzberg, MD

Gregory Malzberg, MD. Attending Psychiatrist & Assistant Clinical Professor, Mount Sinai West, New York, NY. Creator, PsychoFarm.

Dr. Malzberg has no financial relationships with companies related to this material.

We have 30 stimulant formulations, but do all deserve prizes? We find a few with niche advantages, and three that rise to the top.

Research Update

Guanfacine Is Effective and Safe for Children, Adolescents, and Adults

January 1, 2025

Heather Goff, MD

Heather Goff, MD. Dr. Goff has no financial relationships with companies related to this material.

Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

Fact Sheet

ADHD In Adults Inpatient Management

January 1, 2025

Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Adult ADHD can become a contentious issue on the inpatient unit, primarily because the treatment of choice, psychostimulants, is a substance of abuse for some people.

Expert Q&A

ADHD: Beyond Stimulants

January 1, 2025

Nicholas J. Nissen, MD

Nicholas J. Nissen, MD

Concierge psychiatrist, specializing in nonstimulant management of ADHD and anxiety disorders. Austin, TX.

Dr. Nissen has no financial relationships with companies related to this material.

Stimulants may hold the prize for effect size in ADHD, but nonstimulants have advantages for the right patient. Nicholas Nissen shows us how to use five medications, two supplements, and lifestyle approaches in ADHD.